IRF2BP2 and lung carcinoma: Three non-recurrent NTRK1 fusions were each detected in two cases of lung cancer (SQSTM1-NTRK1 and IRF2BP2-NTRK1) and one case of breast cancer (EFNA1-NTRK1).